https://www.selleckchem.com/pr....oducts/Temsirolimus.
53, 95% confidence interval (CI) 0.52-12.25, p = .25 and HR = 2.60, 95% CI 0.54-12.59, p = .24 respectively). TVF free survival was 92.8% vs. 93.5% in patients with versus without stent underexpansion 20% (HR = 1.01, 95% CI 0.21-4.88, p = .99) and 89.3% vs. 97.8% in patients with versus without any residual focal lesion including lumen compromising hematoma (HR = 4.64, 95% CI 0.55-39.22, p = .18). Conclusion Numerically higher TVF rates were observed in patients with a post PCI FFR ≤0.85 and clear focal residual disease as asse
Like
Comment
Share
